Amlodipine 5MG TABLET

Quick links

Choose a section

Quick links to important sections

Advertisements

Amlodipine 5MG TABLET

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Amlodipine 5MG TABLET

Quick Facts

Property Description
Active Ingredient Amlodipine (typically as the besilate salt)
Form Oral tablet
Pharmacological Class Calcium Channel Blocker (Dihydropyridine)
Common Use Managing blood pressure and specific chest discomfort
Origin Synthetic, small-molecule derivative

Classification and Identity: What Type of Medicine is Amlodipine?

Amlodipine 5 mg tablet is a synthetic, prescription-only medication defined by its active component, Amlodipine. The drug is classified within the cardiovascular field, belonging to the Calcium Channel Blocker (CCB) pharmacological class, specifically identified as a Dihydropyridine derivative. This chemical structure provides its key differentiating factor: a long duration of action, which is clinically recognized for supporting a single daily dosing schedule. The product is administered via the oral route in the form of an oral tablet, utilizing the active ingredient Amlodipine besilate alongside solid pharmaceutical excipients necessary for its stability and reliable delivery. Amlodipine is recognized as a drug used to lower blood pressure and prevent chest pain.

Mechanism and Composition: How Does Amlodipine Function as a Vasodilator?

Amlodipine functions primarily as a selective peripheral arterial vasodilator, which means it causes blood vessels in the body to relax and widen. This physiological action occurs because the drug acts as a slow-channel blocker, inhibiting the movement of calcium ions into the vascular smooth muscle cells. The composition of Amlodipine 5 mg tablet is a single-ingredient product, containing only the active pharmaceutical ingredient Amlodipine at the specified strength. Compared to older CCBs, Amlodipine is distinguished by its selective targeting of vascular smooth muscle, minimizing direct action on the heart's conduction system. Amlodipine reduces blood pressure by reducing peripheral vascular resistance.

General Purpose: What is the Main Benefit of Taking Amlodipine?

The main therapeutic benefit of Amlodipine is achieved by consistently promoting arterial relaxation, leading to its categorization as both an Antihypertensive Agent and an Antianginal Agent. This dual categorization is supported by extensive clinical experience, allowing it to be widely used for patients who require management for both conditions simultaneously. As an Antihypertensive Agent, the drug's sustained vasodilatory effect helps to lower and manage high blood pressure. Furthermore, as an Antianginal Agent, the reduced peripheral resistance and improved blood flow contribute to easing the heart’s workload, helping to alleviate certain forms of chest discomfort.

Regulatory References

  1. Amlodipine MedlinePlus Drug Info
  2. NIH Amlodipine Review
Advertisements

What side effects are possible with Amlodipine 5MG TABLET?

Amlodipine is a calcium channel blocker used to manage blood pressure and treat certain types of angina. Its safety profile is documented by regulatory agencies and is characterized by both common, typically mild, adverse reactions and rare, serious events.

Common Adverse Reactions

The most frequently reported side effects are generally related to the drug's vasodilatory action (widening of blood vessels). These common effects, which may be dose-related, include:

  • Oedema (swelling, particularly in the ankles or feet)
  • Headache
  • Fatigue (asthenia)
  • Nausea
  • Dizziness and Somnolence
  • Flushing and Palpitations

Serious and Clinically Significant Adverse Reactions

Although infrequent (very rare), severe adverse reactions have been documented, including myocardial infarction and a worsening of angina, particularly in patients with severe obstructive coronary artery disease upon initiation or dose increase. Other very rare but serious events include hepatitis, jaundice, and severe dermatological reactions like Erythema Multiforme and Stevens-Johnson Syndrome, as well as angioedema.

Safety Restrictions and Specific Population Warnings

  • Contraindications: Amlodipine is contraindicated in patients with known hypersensitivity to dihydropyridine derivatives, severe hypotension, or shock (including cardiogenic shock).
  • Patients with Heart Conditions: Use with caution in patients with congestive heart failure (NYHA Class III and IV) as there is an increased risk of pulmonary oedema, and in those with severe aortic stenosis.
  • Hepatic Impairment: Caution is required in patients with liver impairment, as reduced clearance can lead to increased systemic exposure. Lower starting doses and slow titration are often necessary in this population and in elderly patients.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Officially documented overdose presentations of Amlodipine primarily involve manifestations of excessive peripheral vasodilatation, leading to marked and possibly prolonged systemic hypotension. This severe drop in blood pressure may be accompanied by reflex tachycardia. Urgent medical attention is required for any suspected overdose or when symptoms of clinically significant hypotension are present.

Unmanaged systemic hypotension can escalate to shock with fatal outcome, as defined in the regulatory profile. A potential severe outcome documented is the risk of non-cardiogenic pulmonary oedema, which may manifest with a delayed onset (24 to 48 hours post-ingestion).

Required Emergency Response

If massive overdose should occur, regulatory documents mandate immediate initiation of active cardiac and respiratory monitoring, with frequent blood pressure measurements being essential. Should hypotension persist, cardiovascular support must be provided, including the elevation of the extremities and judicious administration of fluids. If hypotension remains unresponsive to these conservative measures, the use of vasopressors (such as phenylephrine) should be considered, alongside close attention to circulating volume and urine output.

Procedural measures described in the overdose context include the potential for gastric lavage and the administration of activated charcoal within the first hours of ingestion to reduce absorption. Due to the drug being highly protein-bound, official regulatory texts state that dialysis is not likely to be of benefit in overdose management.

Advertisements

Therapeutic Uses of Amlodipine 5MG TABLET

Amlodipine is a medication generally used for managing conditions presenting with acute episodes in the cardiovascular domain, including Hypertension (high blood pressure) and various manifestations of Coronary Artery Disease (CAD). It is relevant in contexts involving heightened systemic burden. The primary therapeutic areas include Hypertension, Chronic Stable Angina, Vasospastic Angina, and conditions presenting with Angiographically Documented CAD.

In these clinical settings, this medication helps ease the overall symptom burden. It contributes to improved comfort during periods of heightened symptoms related to systemic imbalance. For patients experiencing chest pain (angina), the medicine is applied in scenarios where additional management of discomfort is required. This supports the patient during difficult episodes of chest pain.

“It assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.”

Furthermore, in situations where patients experience angiographically documented CAD, the use of amlodipine may be part of symptomatic management. This supports general well-being during symptomatic phases.

Quick Fact: Relief for Angina (Chest Pain)
Supports the patient during difficult episodes of chest discomfort by easing symptoms related to physical discomfort associated with CAD.

Regulatory References

  1. NIH DailyMed Overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Amlodipine 5 MG Tablet

The official eligibility for Amlodipine is defined by specific population groups and pre-existing health conditions, as documented by regulatory authorities.

Contraindicated Populations (Must Not Use)

The medicine is contraindicated and must not be used by patients with:

  • Known hypersensitivity to Amlodipine or other dihydropyridine derivatives.
  • Conditions causing acute circulatory instability, including severe hypotension or shock (e.g., cardiogenic shock).
  • Specific acute heart conditions, such as haemodynamically unstable heart failure following a heart attack or obstruction of the left ventricular outflow tract (e.g., high-grade aortic stenosis).

Age and Condition-Based Restrictions

Population Group Eligibility Status
Adults Generally eligible for all labeled uses.
Children (Ages 6–17) Eligible for hypertension only. Use is not established for children under 6 years.
Older Adults Use requires caution; initiation must start at the low end of the dose range.
Hepatic Impairment Requires conditional use and caution; initial dose must be lowered.
Pregnancy/Lactation Safety in pregnancy is not established. Breastfeeding is generally not recommended.

The regulatory profile explicitly notes that doses exceeding 5 mg have not been studied in pediatric patients. Use in severe renal impairment does not require dose adjustment.

Advertisements

What should I know about interactions with other medicines?

Amlodipine’s official interaction profile is structured around interference with the CYP3A4 metabolic enzyme, coupled with the potential for additive effects on blood pressure, as documented in regulatory labels.


Pharmacokinetic and Exposure-Altering Interactions

Co-administration with strong CYP3A4 inhibitors (such as certain antifungals like ketoconazole, or protease inhibitors) may cause a significant increase in Amlodipine exposure, resulting in a heightened risk of hypotension. Conversely, CYP3A4 inducers, which include rifampicin and the herbal product St. John's Wort, may lead to a reduction in Amlodipine plasma concentration and potentially diminished effect.

A major restriction applies to the co-administration of Simvastatin. Amlodipine officially increases the systemic exposure of Simvastatin, necessitating a regulatory constraint: the Simvastatin dose must be limited and must not exceed 20 mg daily. Similarly, Amlodipine may increase the blood levels of the immunosuppressants Tacrolimus and Cyclosporine, requiring close clinical monitoring.


Pharmacodynamic and Conditional Restrictions

Interactions with other antihypertensive agents (including diuretics, ACE inhibitors, and beta-blockers) result from an expected additive blood pressure-lowering effect. Additionally, co-administration with intravenous Dantrolene should be strictly avoided in patients susceptible to malignant hyperthermia due to potential risks. Consumption of Grapefruit or Grapefruit Juice is not recommended due to the potential to increase Amlodipine bioavailability.


Population-Specific Notes

Amlodipine clearance is officially decreased in patients with hepatic impairment, leading to increased exposure. The clinical effect of altered exposure from CYP3A4 inhibitors **may be more pronounced in the elderly.

Advertisements

Mechanism of Action

Targeted Inhibition of L-type Calcium Ion Channels

Amlodipine functions by selectively blocking the L-type voltage-dependent calcium channels ( L-VDCC) located predominantly on vascular smooth muscle cells . This action prevents the influx of extracellular calcium ions into the cell cytoplasm, which is the necessary molecular signal to initiate muscle contraction.

Reducing Peripheral Vascular Resistance

By inhibiting calcium influx, the drug causes widespread relaxation and widening of the systemic arteries (vasodilation). This physiological change effectively reduces the Peripheral Vascular Resistance ( PVR), leading to a reduction in cardiac afterload (the force opposing ventricular ejection). This sustained reduction in resistance constitutes the core physiological action resulting from the drug's mechanism.

Mechanistic Selectivity and Prolonged Action

Amlodipine is characterized by its high selectivity for vascular channels over those in the cardiac conduction system. Furthermore, its slow dissociation rate from the channel target results in a continuous, prolonged inhibition of calcium influx.

Advertisements

Dosage and Administration Information

How to Use Amlodipine 5MG TABLET

Amlodipine tablets are used via the oral route as a standardized, long-term approach to managing chronic cardiovascular conditions. The medication is typically taken once daily to maintain consistent levels, which is supported by its long duration of action. The tablets can be administered with or without food, granting flexibility in scheduling the daily dose, but should be taken at approximately the same time each day.


Standard Dosing and Adjustment

The most common initial dose for adult patients, including those with hypertension or angina, is 5 mg once daily, although the medication is available in strengths including 2.5 mg and 10 mg. The typical maintenance dose ranges from 5 mg to 10 mg, with 10 mg representing the maximum recommended daily dose for adults.

Population-Specific Use

A lower initial dose of 2.5 mg once daily is used for specific patient populations, including older adults and those with hepatic impairment, due to potential differences in metabolism. For dose adjustments, a titration interval of 7 to 14 days is utilized before any increase, allowing time to assess the full response to the current dose.


Instructions for Missed Doses

If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the subsequent dose, the missed dose should be skipped entirely, and the regular schedule should be resumed. Standard practice indicates that patients should not take two doses at the same time to make up for a missed dose.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Amlodipine 5MG TABLET

This overview describes the types of scientific research that have been conducted for Amlodipine, focusing on the study designs, the outcomes that were measured, and where evidence limitations exist. It summarizes what is known from official and peer-reviewed sources without giving clinical advice.


Evidence for Use in Managing High Blood Pressure (Hypertension)

Research for Amlodipine in high blood pressure includes findings from large-scale Randomized Controlled Trials (RCTs) and very large, long-term studies that compare its use against other medicines. Researchers have explored outcomes related to systemic or functional imbalance by measuring changes in blood pressure. Long-term studies monitored the occurrence of major cardiovascular events, such as stroke or heart attack.

Findings describe patterns observed in the studies related to change in blood pressure measurements across diverse adult populations. Some trials described patterns related to the occurrence of major cardiovascular events when Amlodipine was included in a treatment plan, with different rates observed between groups. The evidence regarding blood pressure changes includes findings from large-scale RCTs, but comparative evidence against every new antihypertensive agent remains limited.


Evidence for Use in Managing Chest Discomfort (Angina)

Amlodipine was studied in research exploring conditions involving periods of heightened symptoms, such as chronic stable angina and the less common vasospastic angina. Studies monitored patient-reported experiences related to physical discomfort by tracking anginal attacks and measuring functional capacity. Findings reported patterns related to changes in symptom frequency and changes in functional capacity.

For vasospastic angina, trials were relevant in assessing short-term or episodic symptom patterns. Findings describe patterns observed in these studies related to changes in the frequency of acute episodes of chest discomfort. However, for both types of angina, data for long-term outcomes, such as major cardiovascular events, remain less extensively documented in large-scale trials focused only on angina patients.


Long-Term Studies and Follow-Up Duration

Long-term studies monitored patient outcomes over periods of up to several years. The evidence contributes to the broader evidence landscape regarding blood pressure changes and event patterns. However, there is limited information for long-term outcomes in certain clinical scenarios, and the durability of the observed findings over decades is not fully established.

Key Studies & References Amlodipine Besylate Tablets Labeling: Primary Regulatory Document

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amlodipine 5MG TABLET (FAQ)


Q: Can Amlodipine 5MG TABLET cause ankle swelling or fluid retention?

According to official product information, oedema (swelling, particularly in the ankles or feet) is a commonly reported adverse reaction. This effect is thought to be related to the way the medicine works by widening blood vessels, and it may be dose-related. The regulatory documents advise that this is one of the most frequently observed side effects.


Q: Is Amlodipine 5MG TABLET approved for use in children?

Regulatory documents indicate that Amlodipine is approved for the treatment of hypertension (high blood pressure) in children who are between 6 and 17 years old. The medicine’s use for other purposes, such as angina, has not been established in this age group. Information regarding its use in children under 6 years of age is limited.


Q: Is Amlodipine 5MG TABLET described as a first-line treatment for high blood pressure?

Yes, regulatory summaries describe Amlodipine as indicated for the first-line treatment of hypertension (high blood pressure). Regulatory sources indicate that it is commonly used as a primary agent to help manage high blood pressure.


Q: What is the potential impact of Amlodipine 5MG TABLET on male fertility, based on studies?

Regulatory warnings mention animal studies indicating adverse effects on male fertility. Reversible biochemical changes in sperm have been observed in some patients using calcium channel blockers. Official documents advise that this information is available for consideration.


Q: Does Amlodipine 5MG TABLET interact with other medicines and products?

Official information confirms that Amlodipine has a documented interaction profile, mainly involving a liver enzyme known as CYP3A4. Taking the medicine with strong inhibitors (drugs that block this enzyme) or inducers (drugs that boost this enzyme) can either increase or decrease the amount of Amlodipine in the body. It is also recommended to limit or avoid grapefruit products.


Q: What are the key differences in how Amlodipine and other common blood pressure medicines work?

Amlodipine is categorized as a Dihydropyridine Calcium Channel Blocker. It works by blocking the movement of calcium into the walls of the blood vessels, causing them to widen. This is distinct from other classes of blood pressure medicine, which rely on different mechanisms, such as affecting the heart rate or influencing hormone systems.


Q: Why do some official sources recommend taking Amlodipine 5MG TABLET in the morning?

Regulatory documents require it to be taken once daily at approximately the same time each day due to its long duration of action. The choice of morning or evening is generally flexible, and official sources prioritize consistency of the daily schedule.


Q: Is Amlodipine 5MG TABLET a beta-blocker?

No, Amlodipine is not a beta-blocker. Regulatory information classifies it as a Dihydropyridine Calcium Channel Blocker. Beta-blockers are a separate class of medicines with a different chemical structure and a different mechanism for lowering blood pressure.


Q: What if my blood pressure goes too low while taking Amlodipine 5MG TABLET?

Regulatory documents list severe hypotension (very low blood pressure) as a contraindication for Amlodipine use. Official product information advises that caution is needed when starting the medicine or when increasing the dose, as this may lead to excessively low blood pressure.


Q: Does Amlodipine 5MG TABLET affect heart rate?

Official adverse event reports list palpitations (a common side effect described as an awareness of a fast or irregular heartbeat). Amlodipine is characterized by a strong selectivity for blood vessel channels, generally minimizing direct action on the heart’s electrical conduction system.


Q: Are there any common supplements that should be avoided with Amlodipine 5MG TABLET?

Regulatory warnings explicitly mention the herbal product St. John's Wort because it can potentially reduce the amount of Amlodipine in the body. Additionally, official documents recommend limiting or avoiding the consumption of grapefruit or grapefruit juice due to the potential for interaction.


Q: Can Amlodipine 5MG TABLET affect sleep?

Official adverse reaction data includes reports of effects on the central nervous system. These include somnolence (drowsiness) as a common effect and insomnia (difficulty sleeping) as an uncommon effect, based on frequency of reporting in clinical trials.


Q: What is the safety classification of Amlodipine 5MG TABLET for use during pregnancy?

Safety for use during human pregnancy is not established by regulatory agencies. In some jurisdictions, Amlodipine is classified under a Category C designation, indicating that while it may be suspected of causing harmful effects on a fetus, this is not necessarily associated with structural malformations.


Q: Do older adults typically need a lower dose of Amlodipine 5MG TABLET?

Yes, official documentation advises initiating treatment for older adults at the low end of the dose range, often 2.5 mg daily. This caution is recommended due to potential age-related differences in how the body processes the medicine and a possible increase in certain effects.


Q: Why is Amlodipine 5MG TABLET sometimes prescribed for people without high blood pressure?

Amlodipine is officially indicated for the symptomatic management of certain forms of angina (chest pain), including chronic stable and vasospastic types. Therefore, the medicine may be prescribed to treat these heart conditions even if the patient does not have co-existing hypertension.


Q: Is the 5MG strength the standard starting dose for Amlodipine?

The 5 mg tablet is documented as the most common initial dose for the majority of adults. However, for certain populations, such as older adults and individuals with impaired liver function, regulatory guidance recommends starting with a lower dose of 2.5 mg once daily.


Q: Are there known effects of Amlodipine 5MG TABLET on kidney function?

Regulatory documents explicitly state that a dose adjustment is not required for patients with severe renal (kidney) impairment. This information is available in the official product documents.


Q: Is Amlodipine 5MG TABLET known to cause any changes in vision?

Official adverse reaction data lists reports of visual disturbances and changes. These effects are classified as uncommon, meaning they are reported less frequently than common side effects like headache or swelling.


Q: What kind of lifestyle changes are mentioned in official documents alongside Amlodipine 5MG TABLET use?

Patient guidance associated with the medicine often emphasizes that it is intended to be used along with changes to one's lifestyle to help control blood pressure. Examples commonly cited include maintaining a healthy diet, exercising regularly, achieving a healthy weight, and not smoking.


Q: Can Amlodipine 5MG TABLET cause changes in blood sugar levels?

Amlodipine is described as safely administered with oral drugs used for diabetes. While safely administered with oral drugs for diabetes, official adverse reaction data for Amlodipine does not commonly list specific effects on blood sugar levels as an adverse event.


Q: Is Amlodipine 5MG TABLET a diuretic ('water pill')?

No. Amlodipine belongs to the pharmacological class of Calcium Channel Blockers. Diuretics, often called 'water pills', are a separate category of medicines that work by directly increasing the amount of water and salt the kidneys excrete.


Q: What is the research evidence theme regarding Amlodipine 5MG TABLET and stroke prevention?

Research evidence, cited in regulatory summaries, includes findings related to the drug's effect on major cardiovascular events. Themes in some studies describe patterns of reduction in the occurrence of events such as stroke when Amlodipine is used as part of a treatment plan for hypertension.


Q: What are the typical expectations for blood pressure reduction after starting Amlodipine 5MG TABLET?

Amlodipine has a gradual onset of effect. Regulatory documents note that steady levels in the blood are typically reached after 7 to 8 consecutive daily doses. Because of this, the full benefit is generally assessed after a 7- to 14-day titration interval.


Q: Can Amlodipine 5MG TABLET be used by people who have had a heart attack?

The medicine is explicitly contraindicated (must not be used) in patients with specific acute circulatory conditions, such as haemodynamically unstable heart failure following a heart attack. Other heart conditions may require conditional use and cautious monitoring.


Q: Is Amlodipine 5MG TABLET generally safe to use with antacids?

General drug interaction information indicates that some antacids containing calcium carbonate may potentially decrease the effect of Amlodipine. Conversely, antacids containing aluminum typically do not show significant documented interactions.


Q: What information is available about Amlodipine 5MG TABLET use in people with asthma?

Clinical information suggests Amlodipine, as a calcium channel blocker, is typically compatible for use in patients who have high blood pressure and co-existing conditions such as asthma. Its mechanism is not associated with adverse effects on the respiratory system.


Q: What are the safety classifications for Amlodipine 5MG TABLET for breastfeeding mothers?

Official documents confirm that Amlodipine is excreted into human milk. Use is not generally recommended while breastfeeding. Official documents require that the risks be considered, and use may necessitate a decision to discontinue the medicine or discontinue breastfeeding.


Q: Does Amlodipine 5MG TABLET help with peripheral artery disease?

While classified as a peripheral arterial vasodilator (meaning it widens blood vessels in the limbs), the official regulatory indications for Amlodipine are limited to treating hypertension and angina.


Q: What is the maximum duration for which Amlodipine 5MG TABLET is typically prescribed?

Amlodipine is designed and indicated for the chronic, long-term management of hypertension and angina. Its long half-life supports a sustained therapeutic benefit, making it suitable for continuous, daily use for these ongoing conditions.


Q: Is it safe to consume alcohol while taking Amlodipine 5MG TABLET?

Patient guidance associated with Amlodipine often mentions that alcohol may further reduce blood pressure levels. This can increase the risk of side effects like dizziness or feeling faint. Patient information leaflets often advise limiting or avoiding alcohol consumption.

Advertisements

How should Amlodipine 5MG TABLET be stored and disposed of?

Storing and Disposing of Amlodipine 5 mg Tablets: Official Requirements

Amlodipine tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C.

Storage Conditions

  • Temperature: Store within the specified Controlled Room Temperature range.
  • Protection: The medicine must be kept protected from light and moisture.
  • Container: Store in the original container to maintain protective conditions.
  • Child Safety: Tablets must be stored out of the sight and reach of children.

️ Disposal Instructions

Unused or expired Amlodipine must be disposed of according to local requirements for pharmaceutical products. Do not dispose of the medication via wastewater or household waste, but utilize local drug take-back or collection schemes.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Amlodipine 5MG TABLET found in:

A-Z Index: